Conformationally constrained analogues of N′-(4-tert-butylbenzyl)-N-(4-methylsulfonylaminobenzyl)thiourea as TRPV1 antagonists
摘要:
A series of bicyclic analogues having indan and tetrahydronaphthalene templates in the A-region were designed as conformationally constrained analogues of our previously reported potent TRPV1 antagonists (1, 3). The activities for rat TRPV1 of the conformationally restricted analogues were moderately or markedly diminished, particularly in the case of the tetrahydronaphthalene analogues. The analysis indicated that steric constraints at the benzylic position in the bicyclic analogues may be an important factor for their unfavorable interaction with the receptor. (C) 2008 Elsevier Masson SAS. All rights reserved.
[EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
申请人:BOEHRINGER INGELHEIM INT
公开号:WO2009062285A1
公开(公告)日:2009-05-22
Compounds of formula (I): wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.
式(I)的化合物:其中R4、R6和R7如本文所定义,可用作HIV复制的抑制剂。
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
申请人:Gilead Sciences, Inc.
公开号:US20130197231A1
公开(公告)日:2013-08-01
Compounds of formula I:
wherein R
4
, R
6
and R
7
are defined herein, are useful as inhibitors of HIV replication.
式I的化合物:
其中R4、R6和R7在此被定义,可用作HIV复制的抑制剂。
Inhibitors of human immunodeficiency virus replication
申请人:GILEAD SCIENCES, INC.
公开号:EP2757096A1
公开(公告)日:2014-07-23
Compounds of formula I:
wherein R4, R6 and R7 are defined herein, are useful as inhibitors of HIV replication.
式 I 的化合物:
其中 R4、R6 和 R7 在本文中定义,可用作 HIV 复制的抑制剂。
US8354429B2
申请人:——
公开号:US8354429B2
公开(公告)日:2013-01-15
Conformationally constrained analogues of N′-(4-tert-butylbenzyl)-N-(4-methylsulfonylaminobenzyl)thiourea as TRPV1 antagonists
作者:Ju-Ok Lim、Mi-Kyoung Jin、HyungChul Ryu、Dong Wook Kang、Jeewoo Lee、Larry V. Pearce、Richard Tran、Attila Toth、Peter M. Blumberg
DOI:10.1016/j.ejmech.2008.02.026
日期:2009.1
A series of bicyclic analogues having indan and tetrahydronaphthalene templates in the A-region were designed as conformationally constrained analogues of our previously reported potent TRPV1 antagonists (1, 3). The activities for rat TRPV1 of the conformationally restricted analogues were moderately or markedly diminished, particularly in the case of the tetrahydronaphthalene analogues. The analysis indicated that steric constraints at the benzylic position in the bicyclic analogues may be an important factor for their unfavorable interaction with the receptor. (C) 2008 Elsevier Masson SAS. All rights reserved.